Chiron presents antiangiogenic and antiproliferative agent targeting growth factor tyrosine kinases July 17, 2003
Discovery of potent, orally active, irreversible Her-2 receptor tyrosine kinase inhibitor reported July 16, 2003
Caspase-dependent cell-killing and TRAIL-sensitizing effects reported for estrogen derivative July 16, 2003
RSS